ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,724.70
0.00%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) Noticias

SPRC

SciSparc (SPRC)

SciSparc Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPRC
FechaHoraFuenteTítuloSímboloCompañía
31/05/202406:17GlobeNewswire Inc.SciSparc Secures Strategic Advantage with Grant of European PatentNASDAQ:SPRCSciSparc Ltd
11/04/202407:15GlobeNewswire Inc.SciSparc to Acquire AutoMaxNASDAQ:SPRCSciSparc Ltd
21/03/202407:58GlobeNewswire Inc.SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer ResearchNASDAQ:SPRCSciSparc Ltd
18/03/202406:29GlobeNewswire Inc.SciSparc Granted Another Patent, Strengthening its Core Technology in CanadaNASDAQ:SPRCSciSparc Ltd
14/03/202407:49GlobeNewswire Inc.SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical TrialNASDAQ:SPRCSciSparc Ltd
12/03/202407:14GlobeNewswire Inc.SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule StructureNASDAQ:SPRCSciSparc Ltd
08/03/202408:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
08/03/202406:11GlobeNewswire Inc.SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
07/03/202406:49GlobeNewswire Inc.SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in EuropeNASDAQ:SPRCSciSparc Ltd
06/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SPRCSciSparc Ltd
06/03/202415:41GlobeNewswire Inc.SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management TechnologyNASDAQ:SPRCSciSparc Ltd
29/02/202407:35GlobeNewswire Inc.SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of DosingNASDAQ:SPRCSciSparc Ltd
27/02/202415:15Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:SPRCSciSparc Ltd
27/02/202406:58GlobeNewswire Inc.SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine CompoundsNASDAQ:SPRCSciSparc Ltd
27/02/202406:58GlobeNewswire Inc.Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine CompoundsNASDAQ:SPRCSciSparc Ltd
20/02/202406:14GlobeNewswire Inc.Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based CompoundsNASDAQ:SPRCSciSparc Ltd
20/02/202406:14GlobeNewswire Inc.SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based CompoundsNASDAQ:SPRCSciSparc Ltd
29/01/202406:18GlobeNewswire Inc.SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
24/01/202406:42GlobeNewswire Inc.SciSparc Ltd. Announces $20 Million Standby Equity Purchase AgreementNASDAQ:SPRCSciSparc Ltd
19/01/202408:28GlobeNewswire Inc.SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 millionNASDAQ:SPRCSciSparc Ltd
04/01/202406:18GlobeNewswire Inc.SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based TreatmentsNASDAQ:SPRCSciSparc Ltd
04/01/202406:18GlobeNewswire Inc.Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based TreatmentsNASDAQ:SPRCSciSparc Ltd
13/12/202307:18GlobeNewswire Inc.SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery PlatformNASDAQ:SPRCSciSparc Ltd
07/12/202308:05GlobeNewswire Inc.SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in IsraelNASDAQ:SPRCSciSparc Ltd
01/12/202307:14GlobeNewswire Inc.Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical TrialNASDAQ:SPRCSciSparc Ltd
28/11/202315:55Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SPRCSciSparc Ltd
28/11/202307:55GlobeNewswire Inc.SciSparc Adopts Limited Duration Shareholder Rights PlanNASDAQ:SPRCSciSparc Ltd
28/11/202307:25GlobeNewswire Inc.SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based TreatmentNASDAQ:SPRCSciSparc Ltd
24/11/202307:55GlobeNewswire Inc.New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
22/11/202306:42GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in IsraelNASDAQ:SPRCSciSparc Ltd
 Showing the most relevant articles for your search:NASDAQ:SPRC

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
CCOM
US500
US 500
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados